Skip to main content
Clifton Bogardus III, MD, Medical Genetics, Phoenix, AZ

CliftonBogardusIIIMD

Medical Genetics • Phoenix, AZ

Physician

Join to view full profile

Dr. Bogardus is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Bogardus' full profile

Already have an account?

  • Office

    4212 N 16th St
    Phoenix, AZ 85016
    Phone+1 602-200-5200
    Fax+1 602-200-5225

Education & Training

  • University of Vermont Medical Center
    University of Vermont Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1979 - 1981
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1977 - 1979
  • Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
    Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalInternship, Internal Medicine, 1974 - 1975
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 1974

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1985 - 2025
  • VT State Medical License
    VT State Medical License 1979 - 1984
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 1986

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • FGF21 Is a Hormonal Mediator of the Human “Thrifty” Metabolic Phenotype  
    Jonathan Krakoff, Clifton Bogardus, Karyne L Vinales, Diabetes Care

Lectures

  • Common Genetic Variation in Glucokinase (GCK) Is Associated with Rates of Carbohydrate Oxidation, Energy Expenditure, and Type 2 Diabetes 
    Phoenix, AZ - 6/14/2014
  • Merging Whole Genome Sequence and Tissue Expression Data to Identify cis-Acting SNPs that Affect Risk for Type 2 Diabetes and Obesity 
    Phoenix, AZ - 6/15/2014
  • Variants in the Promoter of STAM2 Are Associated with Type 2 Diabetes in Pima Indians 
    Phoenix, AZ - 6/16/2014

Press Mentions

  • Association Between Obesity and a Polymorphism in the Beta(1)-Adrenoceptor Gene (Gly389Arg ADRB1) in Caucasian Women
    Association Between Obesity and a Polymorphism in the Beta(1)-Adrenoceptor Gene (Gly389Arg ADRB1) in Caucasian WomenJuly 22nd, 2020

Dr. Clifton Bogardus, Dr. Clifton Bogardus, MD, Dr. C Bogardus